Epithelial MLCK-dependent barrier dysfunction mediates T-cell activation-induced diarrhea in vivo Cytoskeletal contraction due to myosin II (regulatory)-light chain (MLC) phosphorylation is necessary for barrier disruption and in vitro inhibition of myosin light chain kinase (MLCK) restores barrier function following cytokine treatment
Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis
A lightweight, non-sticky gel formulated with Glutathione, Vitamin B5, Niacinamide, and Vitamin E
Efficacy and safety of cathine (nor-pseudoephedrine) in the treatment of obesity: a randomized dose-finding study
FDA URGES CLINICAL TRIALS There are many peptides, such as insulin and GLP-1 drugs, that have been approved by the health regulator
[DOI] [PMC free article] [PubMed] [Google Scholar] 13.Sjdin K., Nilsson E., Hallberg A., Tunek A